Cover storyHow a compliant environmental monitoring programme became a blindfold, and what every sterile facility should ask before the next contamination event.
Roche's second India digital hub in Hyderabad, due Q1 2027, expands its global technology network supporting manufacturing and quality operations.
FDA grants Sanofi concurrent annual approval for Fluzone and Fluzone High-Dose, confirming 2026–27 seasonal authorization under STN BL 103914.
FDA approves FluLaval Quadrivalent for 2026–2027 season; lot release and GMP compliance timelines now active for ID Biomedical.
FDA approves Seqirus Flucelvax for 2026–2027 season on July 1, continuing annual cell-based influenza vaccine approval cycle.
FDA is investigating sevoflurane and volatile anesthetics after neurologic deaths linked to a rare mitochondrial variant in Venezuelan-ancestry patients.
20260622153015.png&w=1920&q=75)
Interview
Interview
Interview
People on the moveMarcus Adeyemi, previously VP of Sterile Operations at Sterigenix, has been appointed Chief Executive Officer of Aventa CDMO effective July 2026.
Sponsored
Sponsored
Sponsored
Sep 16
Sep 28From native content to event partnerships, we help brands earn the attention of a hard-to-reach, senior audience — without breaking the reading experience.
See partnership options →Explore expert-led guides crafted for pharma professionals. Log in to download and stay ahead.
Join thousands of pharma professionals getting our sharpest reporting, briefings and guides — free.
